Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
      Description

      The purpose of this extension study is to determine if leuprolide acetate (11.25 mg and 30 mg) is safe in treating children with Central Precocious Puberty over a longer period of time (36 months).

      Conditions
      PrecociousLeuprolide AcetateLuteinizing Hormone (LH)Gonadotrophin-releasing Hormone Agonist (GnRHa)Tanner StagingDepot FormulationSuppression of LHCentral Precocious Puberty (CPP)Gonadotrophin-releasing Hormone (GnRH)LupronGnRH AnalogPediatrics Central Precocious Puberty
      Talk to us
      COMPLETED
      Study of Lupron Depot In The Treatment of Central Precocious Puberty
      Description

      The purpose of this study is to determine if Lupron (leuprolide acetate) is safe and effective in treating children with Central Precocious Puberty (CPP), and to assess long term effects of leuprolide acetate treatment after therapy is discontinued.

      Conditions
      Puberty, Precocious
      Talk to us